Clinical Trial Biorepository and Archiving Solutions Market Size & Growth Forecast 2027–2036, By Segments (Service, Phase, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Clinical Trial Biorepository and Archiving Solutions Market size was around USD 5 billion in 2026 and is slated to grow at a 8.08% CAGR from 2027 to 2036, attaining USD 10.87 billion by 2036. The industry revenue for 2027 is assessed at USD 5.34 billion.
Get more details on this report
Request Free Sample ReportClinical Trial Biorepository and Archiving Solutions Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 40.49% share, driven by dense biopharmaceutical sponsors, CRO networks, strong compliance requirements, and advanced cold-chain infrastructure supporting regulated clinical research and secure sample management workflows.
- Asia Pacific grows at 9.38% CAGR due to rising clinical trial activity, expanding research infrastructure, and increasing need for standardized biospecimen storage and coordinated multi-site trial sample management systems.
Segment Momentum
- Biorepository Services held a 66.06% market share in 2026 because clinical trials rely on standardized sample preservation, chain-of-custody control, and reliable biological sample management across multicenter studies.
- Archiving Solution Services are growing fastest as organizations prioritize compliant long-term record retention, traceability, and efficient retrieval to support audits, regulatory reviews, and expanding clinical trial documentation.
Market Expansion Drivers
- Growing pharmaceutical clinical trial activity increasing demand for secure biospecimen storage solutions.
- Stringent FDA and ICH-GCP compliance requirements accelerating adoption of advanced archiving infrastructure.
- Expansion of decentralized and multi-regional CRO-led trials increasing outsourced biorepository service demand.
Leading Market Participants
- Major players in the clinical trial biorepository and archiving solutions market include Thermo Fisher Scientific Inc. (United States), Azenta, Inc. (United States), Charles River Laboratories International, Inc. (United States), Labcorp Holdings Inc. (United States), Medpace Holdings, Inc. (United States), Precision Medicine Group, LLC (United States), Q² Solutions (United States), LabConnect, LLC (United States), Cryoport, Inc. (United States), American Type Culture Collection (ATCC) (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 5 billion
- 2027 Estimated Market Size: USD 5.34 billion.
- Projected Market Size: USD 10.87 billion by 2036
- Growth Forecast: 8.08% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Biorepository Services (Service) | Phase III (Phase) | Clinical Products (Product)
- Emerging Opportunity Segment: Archiving Solution Services (Service) | Preclinical (Phase) | Stem Cells (Product)
Market Growth Drivers and Industry Trends
Growing pharmaceutical clinical trial activity increasing demand for secure biospecimen storage solutions
Increasing clinical research activity is expanding the volume and diversity of biological specimens that must be preserved under controlled conditions, supporting the clinical trial biorepository and archiving solutions market. Biospecimens collected during trials may require carefully managed storage, tracking, retrieval, and documentation to maintain their integrity throughout the research lifecycle. Secure biorepository infrastructure enables sponsors and research organizations to preserve samples for ongoing analysis, validation, and future research while maintaining reliable links between specimens and associated clinical information.
Stringent FDA and ICH-GCP compliance requirements accelerating adoption of advanced archiving infrastructure
Regulatory expectations surrounding clinical research documentation, specimen traceability, data integrity, and controlled handling are encouraging organizations to strengthen their archiving capabilities. The clinical trial biorepository and archiving solutions market benefits from demand for infrastructure that supports standardized procedures, audit readiness, controlled access, and comprehensive records throughout the specimen lifecycle. Advanced systems can also improve inventory visibility and chain-of-custody management, helping research organizations maintain consistent documentation across complex clinical programs.
Expansion of decentralized and multi-regional CRO-led trials increasing outsourced biorepository service demand
The growing use of decentralized and geographically distributed clinical trials is increasing the complexity of biospecimen collection, transportation, storage, and retrieval across multiple locations. This trend is supporting the clinical trial biorepository and archiving solutions market as pharmaceutical sponsors increasingly rely on specialized service providers to manage specimen logistics and long-term storage requirements. CRO-led trial models can require coordinated biorepository operations across different research sites and regions, creating greater demand for centralized inventory management, standardized handling procedures, and secure specimen preservation.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Growing pharmaceutical clinical trial activity increasing demand for secure biospecimen storage solutions | 2.00% | High | North America, Europe, Asia Pacific | High | Near Term |
| Stringent FDA and ICH-GCP compliance requirements accelerating adoption of advanced archiving infrastructure | 1.80% | High | North America, Europe | High | Mid Term |
| Expansion of decentralized and multi-regional CRO-led trials increasing outsourced biorepository service demand | 1.50% | Moderate | Asia Pacific, Latin America | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America accounted for the largest share of the clinical trial biorepository and archiving solutions market in 2026, representing 40.49% share, supported by a mature clinical research ecosystem, extensive biopharmaceutical development activity, and established requirements for secure biological sample management and long-term data preservation. The region's sophisticated research infrastructure enables widespread use of specialized biorepository services throughout clinical development, while stringent requirements for sample integrity, traceability, documentation, and regulatory compliance reinforce demand for reliable archiving solutions. Increasing complexity in clinical research and the growing importance of high-quality biological specimens for translational research are also encouraging investments in advanced storage, tracking, and information-management capabilities.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is experiencing the fastest regional growth, driven by expanding clinical research activity, improving research infrastructure, and increasing participation in global drug development programs. Growing investment in healthcare and life sciences is strengthening the need for organized biological sample collection, preservation, and retrieval capabilities across emerging research hubs. Greater adoption of standardized clinical research practices is also encouraging institutions to improve sample traceability and long-term archival processes. As pharmaceutical and biotechnology research expands across the region, demand for scalable biorepository infrastructure and digitally enabled sample management is increasing, creating favorable conditions for continued market development.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants/Startups i Scale Low Medium High | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Quality-Driven BiobankingGermany prioritizes standardized biobanking practices that reinforce specimen integrity and regulatory compliance across clinical research programs. The country continues to adopt advanced storage automation and traceability solutions to strengthen research reproducibility and operational consistency.
France 🇫🇷
Research Infrastructure SupportFrance strengthens biorepository capabilities through research institutions seeking harmonized storage, documentation, and sample governance practices. The country increasingly values archiving solutions that facilitate collaborative clinical studies while maintaining compliance with evolving research standards.
Italy 🇮🇹
Clinical Storage ModernizationItaly is modernizing clinical biorepository operations with greater attention to secure specimen preservation and efficient archive management. Healthcare and research organizations increasingly implement automated storage systems that improve operational reliability and regulatory readiness.
Japan 🇯🇵
Precision Sample PreservationJapan focuses on high-quality preservation technologies that maintain sample stability for precision medicine and translational research. Clinical organizations increasingly invest in reliable archiving systems that support long-term storage while meeting rigorous quality management requirements.
South Korea 🇰🇷
Digital Repository IntegrationSouth Korea is expanding digitally connected biorepository infrastructure to improve clinical sample accessibility and workflow coordination. The market favors integrated archiving platforms that enhance traceability, research collaboration, and efficient specimen lifecycle management.
United States 🇺🇸
Multi-Site Sample ManagementThe U.S. emphasizes scalable biorepository and archiving solutions that support complex multi-center clinical trials and stringent regulatory documentation. Demand is centered on integrated digital tracking, secure long-term specimen storage, and operational efficiency across research networks.
Segment Leadership and Growth Trends
Clinical Trial Biorepository and Archiving Solutions Market Share (%), by Service, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportService Segment Analysis: Biorepository Services (Largest Segment) vs Archiving Solution Services (Fastest-Growing Segment)
Biorepository services held the largest share of the clinical trial biorepository and archiving solutions market, accounting for 66.06% in 2026, reflecting the critical role of controlled biological sample collection, storage, tracking, and retrieval throughout clinical research programs. Clinical trials generate valuable specimens that must remain traceable and preserved under appropriate conditions to support current and potential future research requirements. Growing emphasis on sample integrity, regulatory compliance, chain-of-custody management, and standardized laboratory processes reinforces demand for specialized biorepository capabilities. Archiving solution services are expanding at the fastest pace as sponsors and research organizations face growing requirements to retain trial documentation and associated records in secure, accessible, and compliant environments. Increasing digitization, electronic document management, data governance, and long-term retention requirements are strengthening demand for more sophisticated archiving solutions.
Phase Segment Analysis: Phase III (Largest Segment) vs Preclinical (Fastest-Growing Segment)
Phase III represented the largest phase segment in the clinical trial biorepository and archiving solutions market, reflecting the substantial volume and complexity of biological samples and research records generated during large-scale, late-stage clinical development. These studies typically require rigorous sample management, documentation, traceability, and long-term preservation to support extensive analysis and regulatory requirements. The preclinical segment is growing at the fastest pace as pharmaceutical and biotechnology research increasingly emphasizes structured sample management earlier in the development lifecycle. Greater reliance on translational research, biomarker investigations, laboratory data, and organized preservation of research materials is encouraging researchers to establish stronger biorepository and archiving practices before candidates advance into clinical testing.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Service | Biorepository Services, Archiving Solution Services | Biorepository Services | Archiving Solution Services |
| Phase | Preclinical, Phase I, Phase II, Phase III, Phase IV | Phase III | Preclinical |
| Product | Preclinical Products, Clinical Products, Human Tissue, Organs, Stem Cells, Others | Clinical Products | Stem Cells |
Competitive Landscape and Market Positioning
Prominent players in the clinical trial biorepository and archiving solutions market:
1. Thermo Fisher Scientific Inc. (United States)
2. Azenta Inc. (United States)
3. Charles River Laboratories International Inc. (United States)
4. Labcorp Holdings Inc. (United States)
5. Medpace Holdings Inc. (United States)
6. Precision Medicine Group LLC (United States)
7. Q² Solutions (United States)
8. LabConnect LLC (United States)
9. Cryoport Inc. (United States)
10. American Type Culture Collection (ATCC) (United States)
The clinical trial biorepository and archiving solutions market is evolving with stronger integration of digital storage and sample management systems. Collaborative networks are improving research coordination and data integrity. New solution launches are enhancing storage security and traceability, while ecosystem development is strengthening clinical research efficiency.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Azenta Inc. (United States) | |||||||
| Charles River Laboratories International Inc. (United States) | |||||||
| Labcorp Holdings Inc. (United States) | |||||||
| Medpace Holdings Inc. (United States) | |||||||
| Precision Medicine Group LLC (United States) | |||||||
| Q² Solutions (United States) | |||||||
| LabConnect LLC (United States) | |||||||
| Cryoport Inc. (United States) | |||||||
| American Type Culture Collection (ATCC) (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Cryoport (CRYOGENE) | Jan-25 | Cryoport’s CRYOGENE unit announced a strategic partnership with Moffitt Cancer Center to establish a 30,000-square-foot, state-of-the-art biorepository at the Speros FL campus. The facility provides secure, temperature-controlled storage ranging from 23°C down to -200°C (liquid nitrogen), designed to support advanced research in cell and gene therapy, immunotherapies, and radiopharmaceuticals. |
| Azenta Life Sciences | Jan-25 | Azenta inaugurated a new biorepository facility in the Greater Boston area to serve as a local hub for life sciences. The site offers same-day sample retrieval, courier services, and storage across a range of temperatures (from controlled room temperature to -190°C), utilizing advanced automated storage systems like the BioArc™ Ultra to ensure sample integrity for clinical trials and manufacturing. |
| LabConnect | Apr-24 | LabConnect completed the acquisition of A4P Consulting Ltd, a UK-based scientific consultancy. The acquisition integrates A4P’s specialized expertise in biomarker strategy, bioanalytical project management, and logistics solutions into LabConnect’s central laboratory services, enhancing its ability to support the complex requirements of preclinical and clinical trials globally. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Clinical Trial Biorepository and Archiving Solutions Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Sponsor Type | Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations |
| Storage Modality | Ambient Storage, Refrigerated Storage, Frozen Storage, Cryogenic Storage |
| Therapeutic Area | Oncology, Immunology & Inflammation, Neurology, Cardiovascular Diseases, Infectious Diseases, Other Therapeutic Areas |
Clinical Trial Biorepository and Archiving Solutions Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Biopharmaceutical Sample Management Strategy Assessment |
|
| Sponsor and CRO Procurement Benchmarking |
|
| Clinical Research Digitization Opportunity Analysis |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the clinical trial biorepository and archiving solutions market generate?
How is the clinical trial biorepository and archiving solutions industry size expected to evolve during the forecast period?
How are expanding pharmaceutical clinical trials reshaping procurement priorities in the clinical trial biorepository and archiving solutions market?
Why is outsourced biorepository infrastructure gaining strategic importance in decentralized clinical trials?
Why do Biorepository Services lead the clinical trial biorepository and archiving solutions market?
Why are Archiving Solution Services the fastest-growing service segment in the clinical trial biorepository and archiving solutions market?
Why does North America lead the clinical trial biorepository and archiving solutions market?
What is driving Asia Pacific’s fastest growth in this market?
What are the prominent companies operating in the clinical trial biorepository and archiving solutions landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization